#ExistRefRangeSet>
Reference Interval:
#ExistRefRangeTable> | Available Separately
| Components
| Reference Interval
| | | Saccharomyces cerevisiae Antibody, IgG
| £ 20 Units: No Antibody Detected 21-24 Units: Equivocal ³ 25 Units: Positive
| | | Saccharomyces cerevisiae Antibody, IgA
| £ 20 Units: No Antibody Detected 21-24 Units: Equivocal ³ 25 Units: Positive
| | | Anti-Neutrophil Cytoplasmic Antibody, Atypical Pattern
| < 1:20: Not significant
| |
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>P-ANCA antibodies are found in 50-70% of ulcerative colitis (UC) patients, but in only 20% of Crohn disease (CD) patients. In contrast, Saccharomyces cerevisiae IgG antibodies are found in 80% of CD patients, but only 20% of UC patients. Saccharomyces cerevisiae IgA antibodies are found in 35% of CD patients but < 1% in UC patients.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
This test may be a useful tool for distinguishing ulcerative colitis (UC) from Crohn disease (CD) in patients with suspected inflammatory bowel disease.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
86671 x2 Semiquantitative immunoassay-fungus not elsewhere specified; 86255 Fluorescent noninfectious agent antibody screen
|
*ExistCPT>